Excel® Lactated Ringers Injection, 1000mL

  • Presence of particulate matter identified primarily as cellulose cotton fibers, with individual particles also identified as cellulose wood fiber and polystyrene
  • Company: (B. Braun)
  • Drugs
  • FDA
  • August 19, 2026

Product details

  • Excel® Lactated Ringers Injection, 1000mL

Company announcement

B. Braun Medical Inc. is voluntarily recalling one lot of Excel® Lactated Ringers Injection, 1000mL.

The product was distributed nationwide in the United States and to Canada from August 29, 2024, through September 30, 2024.

The recall is due to the presence of particulate matter, identified primarily as cellulose cotton fibers, with individual particles also identified as cellulose wood fiber and polystyrene.

No adverse events related to this recall have been reported to date. The announcement was made on August 19, 2026.

Risk:

The use of the defective product has a reasonable probability of causing pulmonary emboli (blockage in pulmonary blood vessels), occlusions of other blood vessels (which can lead to tissue death and possible organ damage), and/or phlebitis (inflammation of the walls of veins, which may lead to clotting). Systemically, foreign particles infused intravenously can cause systemic activation of the immune system, organ dysfunction, and hemolysis (breakdown of blood cells). To date, B. Braun has not received any reports of adverse events related to this recall.

Impacted states: Nationwide

Products:

- B. Braun Excel® Container Lactated Ringers Injection, 1000ml (UPC code(s): 0264775000)

Contact

For more information, email recalls@bbraunusa.com.

View the original FDA notice

Browse all recalls

Related recalls